Literature DB >> 29634818

Sequencing of Tumor DNA to Guide Cancer Risk Assessment and Therapy.

David H Spencer1, Timothy J Ley1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29634818     DOI: 10.1001/jama.2018.2281

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Multi-analyte assays and early detection of common cancers.

Authors:  Robert P Young; Timothy Christmas; Raewyn J Hopkins
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.

Authors:  Erica K Barnell; Kenneth F Newcomer; Zachary L Skidmore; Kilannin Krysiak; Sydney R Anderson; Lukas D Wartman; Stephen T Oh; John S Welch; Keith E Stockerl-Goldstein; Ravi Vij; Amanda F Cashen; Iskra Pusic; Peter Westervelt; Camille N Abboud; Armin Ghobadi; Geoffrey L Uy; Mark A Schroeder; John F Dipersio; Mary C Politi; David H Spencer; Eric J Duncavage; Timothy J Ley; Malachi Griffith; Meagan A Jacoby; Obi L Griffith
Journal:  JCO Precis Oncol       Date:  2021-01-14

3.  Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.

Authors:  Stephen E Lincoln; Robert L Nussbaum; Allison W Kurian; Sarah M Nielsen; Kingshuk Das; Scott Michalski; Shan Yang; Nhu Ngo; Amie Blanco; Edward D Esplin
Journal:  JAMA Netw Open       Date:  2020-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.